Medical News

RSS

Miniature camera to provide live images of inside of the body

The world's first 'fantastic voyage' in which a miniature camera will broadcast live images of the inside of the body is set to take place this Sunday.

11 Sep 2009

NAMI: Uniformity of insurance coverage for mental illness and addictive disorders

NAMI agrees with President Obama that the time for action on health care reform is now. It is time for both Democrats and Republicans to come together and deliver on what, for too many years, have only been promises.

11 Sep 2009

HCD Research to conduct a national study during President Barack Obama's speech on health care reform

HCD Research announced today that it will conduct a national study during President Barack Obama's speech on health care reform tonight to obtain Americans' perceptions of the president and his plan for health care reform.

11 Sep 2009

Tetraphase to present its study on novel classes of antibiotics to treat drug-resistant infections

Tetraphase Pharmaceuticals Inc., a biopharmaceutical company capitalizing on breakthrough synthetic chemistry technology announced today that it will present three (3) posters and deliver a slide presentation on the synthesis and antibacterial activity of analogs from several novel classes of antibiotics to treat drug-resistant infections at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA.

11 Sep 2009

Plastic surgeons in disaster-relief efforts can improve long-term outcomes for victims

When a terrorist bomb explodes, a tornado rips through a town, a hurricane devastates a region, or wildfires ravage homes and businesses, plastic surgeons are not typically atop the list of emergency responders.

11 Sep 2009

Update on Prolindac clinical development plan provided by Access Pharmaceuticals

ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), provided an update today on the Company's clinical development plan for ProLindac, a novel DACH platinum drug that has shown to be active in many solid tumor types in human clinical studies.

11 Sep 2009

Cellular mechanosensory system may yield new insights for cancer therapy

Every moment, millions of a body's cells flawlessly divvy up their genes and pinch perfectly in half to form two identical progeny for the replenishment of tissues and organs - even as they collide, get stuck, and squeeze through infinitesimally small spaces that distort their shapes.

11 Sep 2009

Majority of Americans want Congress to include lawsuit reform in the health care bill: Survey

A new nationwide poll reveals that a strong majority of America's voters want Congress to include lawsuit reform in any overhaul of the health care system.

11 Sep 2009

Careless practices takes a heavy toll on American lives, says President of SAVE THE PATIENT

Is anyone listening? As this debate rages on about medical reform, patient safety organizations, those of us at the front each and every day, we do not hear about what is happening to the people from the senseless health care devastation throughout our country right now.

11 Sep 2009

ERC funds DiaDrug project to study the link between insulin resistance and albuminuria

The European Research Council (ERC) expects to fund some 240 top researchers in its second prestigious ERC Starting Grant competition. This new wave of grantees follows the 299 researchers who received grants in the first Starting Grant competition in 2007. In total, 2503 proposals were submitted to the second Starting Grant call.

11 Sep 2009

Amylin and Biocon collaborate to develop a peptide therapeutic for treating diabetes

Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Biocon, Limited (NSE: BIOCON) announced today that they have entered into an exclusive agreement to jointly develop, commercialize and manufacture a novel peptide therapeutic for the potential treatment of diabetes. Amylin and Biocon will collaborate to develop the therapeutic potential of the compound and share development costs. Research will center on Amylin's "phybrid" technology.

11 Sep 2009

Medical institutes sponsor education newsletter series on angioedema

Angioedema is characterized by episodes of intense localized edema involving the skin, visceral organs, and airway, causing discomfort and even death as a result of airway obstruction. There are a number of therapies available for the prevention and treatment of angioedema, and new therapies are being studied to further minimize the effect of acute attacks on this patient population.

11 Sep 2009

Scarab Genomics and Neoclone sign license agreement

Scarab Genomics, a leader in E coli technology, has entered into a license agreement with NeoClone to market and distribute their proprietary antibodies against Shiga toxin.

11 Sep 2009

ASCEND program helps achieve rapid improvements in supply chain performance

Hospitals and health systems participating in the Premier healthcare alliance’s ASCEND (Accelerated Supply Chain Endeavor) program have reduced their supply expenses in recently launched categories by up to 24 percent since May 2009.

11 Sep 2009

Culinary Software adds Allergen Alerts functionality to its ChefTec software

Culinary Software Services, Inc., the leading provider of back-of-the-house technology for the foodservice industry, announces the addition of Allergen Alerts to its ChefTec software. Under the Food Allergen Labeling & Consumer Protection Act, the FDA requires food labels to clearly state if food products contain any ingredients from the eight major allergenic foods.

11 Sep 2009

The U.S. Food and Drug Administration reorganizes and updates its warning letters web page

The U.S. Food and Drug Administration has reorganized and updated the warning letters page in the Inspections, Compliance, Enforcement, and Criminal Investigations section of the FDA Web site.

11 Sep 2009

Recession hits some biopharmaceutical companies and CROs

Recession-driven slowdowns in drug development mean problems for some biopharmaceutical companies and, by extension, the contract research organizations (CROs) they employ to test prospective therapies.

11 Sep 2009

Merck update on the status of telcagepant clinical development programs

Merck & Co., Inc. today updated the status of the clinical development programs for telcagepant (MK-0974) and MK-3207, the Company's investigational oral calcitonin gene-related peptide (CGRP) receptor antagonists for the intermittent treatment of acute migraine.

11 Sep 2009

President Barack Obama's speech on health care reform receives mixed reactions

A new national media study among 951 viewers of President Barack Obama's speech to Congress in which he focused on his plan for health care reform revealed that more than half of all political parties reported that the speech was "somewhat or extremely effective."

11 Sep 2009

Positive results from Mpex' Phase 2b clinical trial with Aeroquin

Mpex Pharmaceuticals, Inc. today announced positive data from its Phase 2b clinical trial with Aeroquin((R)) (a novel aerosol formulation of levofloxacin, MP-376) in cystic fibrosis (CF). Trial results showed that nebulized Aeroquin met the primary endpoint of reducing bacterial counts of Pseudomonas aeruginosa (P. aeruginosa) in sputum after 28 days of dosing versus placebo.

11 Sep 2009

Medical News

Miniature camera to provide live images of inside of the body

NAMI: Uniformity of insurance coverage for mental illness and addictive disorders

HCD Research to conduct a national study during President Barack Obama's speech on health care reform

Tetraphase to present its study on novel classes of antibiotics to treat drug-resistant infections

Plastic surgeons in disaster-relief efforts can improve long-term outcomes for victims

Update on Prolindac clinical development plan provided by Access Pharmaceuticals

Cellular mechanosensory system may yield new insights for cancer therapy

Majority of Americans want Congress to include lawsuit reform in the health care bill: Survey

Careless practices takes a heavy toll on American lives, says President of SAVE THE PATIENT

ERC funds DiaDrug project to study the link between insulin resistance and albuminuria

Amylin and Biocon collaborate to develop a peptide therapeutic for treating diabetes

Medical institutes sponsor education newsletter series on angioedema

Scarab Genomics and Neoclone sign license agreement

ASCEND program helps achieve rapid improvements in supply chain performance

Culinary Software adds Allergen Alerts functionality to its ChefTec software

The U.S. Food and Drug Administration reorganizes and updates its warning letters web page

Recession hits some biopharmaceutical companies and CROs

Merck update on the status of telcagepant clinical development programs

President Barack Obama's speech on health care reform receives mixed reactions

Positive results from Mpex' Phase 2b clinical trial with Aeroquin

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Latest News